US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

(TSX:SVA)

0.1150 UNCHANGED
Delayed Quote Updated: 3:59 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SVA

< Previous 1 2 3 4 Next >
News headline image
SINOVAC Reports Unaudited First Half of 2026 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Reports Unaudited First Half of 2025 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing. 
Via The Motley Fool
News headline image
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials. 
Via The Motley Fool
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
Issued on behalf of Avant Technologies Inc. 
From USA News Group
Via GlobeNewswire
News headline image
Newly Elected Directors of Sinovac Hold the First Board Meeting
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting
From SAIF Partners IV L.P.
Via Business Wire
News headline image
Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote
From Vivo Capital
Via Business Wire
News headline image
CORRECTING and REPLACING SAIF Partners: Now is Your Last Chance to Vote for Board Change at Sinovac
From SAIF Partners IV L.P.
Via Business Wire
News headline image
United States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding Sinovac
From Vivo Capital
Via Business Wire
News headline image
SAIF Partners Sends Letter to Sinovac Shareholders
From SAIF Partners IV L.P.
Via Business Wire
News headline image
SAIF Partners Sends Open Letter to Sinovac Shareholders Outlining Current Board’s Failure to Act in the Interests of Shareholders
From SAIF Partners IV L.P.,
Via Business Wire
News headline image
Sinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 Dividend ↗
A U.S. court denied an emergency injunction sought by dissenting investors, while a separate case in Antigua could unlock an additional $11 per share if disputed PIPE shares are invalidated. 
Via Stocktwits
News headline image
Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting
From Prime Success L.P.
Via Business Wire
News headline image
SINOVAC Announces New Board Member
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Prime Success Sets the Record Straight Regarding Continued False and Misleading Statements from Sinovac Biotech’s Current Board
From Prime Success L.P.
Via Business Wire
News headline image
SAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the Board
From SAIF Partners IV L.P.
Via Business Wire
News headline image
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success’ New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
From SINOVAC Biotech Ltd.
Via Business Wire
News headline image
Prime Success Responds to Sinovac Biotech’s False and Misleading Claims
From Prime Success L.P.
Via Business Wire
< Previous 1 2 3 4 Next >